FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2260488093> ?p ?o ?g. }

• W2260488093 endingPage "23" @default.
• W2260488093 startingPage "13" @default.
• W2260488093 abstract "Vascular endothelial dysfunction is regarded as the initial step of vascular complications in diabetes mellitus. This study investigated the amelioration of apigenin and naringenin in type 2 diabetic (T2D) rats induced by high-fat diet and streptozotocin and explored the underlying mechanism. Apigenin or naringenin was intragastrically administered at 50 or 100 mg/kg once a day for 6 weeks. Biochemical parameters including blood glucose, glycated serum protein, serum lipid, insulin, superoxide dismutase (SOD), malonaldehyde and intercellular adhesion molecule-1 (ICAM-1) were measured. Vascular reactivity in isolated thoracic aortic rings was examined. Pathological features of the thoracic aorta were further observed through optical microscopy and transmission electron microscopy. Lastly, we evaluated their effects on insulin resistance of palmitic acid (PA)-induced endothelial cells. Compared with diabetic control group, apigenin and naringenin significantly decreased the levels of blood glucose, serum lipid, malonaldehyde, ICAM-1 and insulin resistance index, increased SOD activity and improved impaired glucose tolerance. Apigenin and naringenin restored phenylephrine-mediated contractions and acetylcholine or insulin-induced relaxations in aortic tissues. Furthermore, pathological damage in the thoracic aorta of apigenin and naringenin groups was more remissive than diabetic control group. In vitro, apigenin and naringenin inhibited NF-κB activation and ICAM-1 mRNA expression in PA-treated endothelial cells and improved nitric oxide production in the presence of insulin. In conclusion, both apigenin and naringenin can ameliorate glucose and lipid metabolism, as well as endothelial dysfunction in T2D rats at least in part by down-regulating oxidative stress and inflammation. In general, apigenin showed greater potency than naringenin equivalent." @default.
• W2260488093 created "2016-06-24" @default.
• W2260488093 creator A5036923059 @default.
• W2260488093 creator A5054459491 @default.
• W2260488093 creator A5054977676 @default.
• W2260488093 creator A5055299862 @default.
• W2260488093 creator A5056588504 @default.
• W2260488093 creator A5065018071 @default.
• W2260488093 creator A5069730600 @default.
• W2260488093 creator A5071911403 @default.
• W2260488093 creator A5091796903 @default.
• W2260488093 date "2016-02-01" @default.
• W2260488093 modified "2023-10-16" @default.
• W2260488093 title "Apigenin and naringenin regulate glucose and lipid metabolism, and ameliorate vascular dysfunction in type 2 diabetic rats" @default.
• W2260488093 cites W1718201877 @default.
• W2260488093 cites W1905855640 @default.
• W2260488093 cites W1964906337 @default.
• W2260488093 cites W1965557105 @default.
• W2260488093 cites W1967949180 @default.
• W2260488093 cites W1975320072 @default.
• W2260488093 cites W1978136788 @default.
• W2260488093 cites W1989213603 @default.
• W2260488093 cites W1998062110 @default.
• W2260488093 cites W1999091695 @default.
• W2260488093 cites W2005392863 @default.
• W2260488093 cites W2007617327 @default.
• W2260488093 cites W2012307304 @default.
• W2260488093 cites W2012458878 @default.
• W2260488093 cites W2013974284 @default.
• W2260488093 cites W2018185635 @default.
• W2260488093 cites W2018626994 @default.
• W2260488093 cites W2019630907 @default.
• W2260488093 cites W2021768759 @default.
• W2260488093 cites W2023285609 @default.
• W2260488093 cites W2027946048 @default.
• W2260488093 cites W2032474965 @default.
• W2260488093 cites W2034405513 @default.
• W2260488093 cites W2035085337 @default.
• W2260488093 cites W2039762060 @default.
• W2260488093 cites W2040783439 @default.
• W2260488093 cites W2042924742 @default.
• W2260488093 cites W2044837419 @default.
• W2260488093 cites W2062769455 @default.
• W2260488093 cites W2063757091 @default.
• W2260488093 cites W2064640260 @default.
• W2260488093 cites W2066675191 @default.
• W2260488093 cites W2066718767 @default.
• W2260488093 cites W2070478981 @default.
• W2260488093 cites W2072345056 @default.
• W2260488093 cites W2097880694 @default.
• W2260488093 cites W2103450921 @default.
• W2260488093 cites W2112682556 @default.
• W2260488093 cites W2121129782 @default.
• W2260488093 cites W2127780525 @default.
• W2260488093 cites W2137956702 @default.
• W2260488093 cites W2138562665 @default.
• W2260488093 cites W2139452495 @default.
• W2260488093 cites W2143593450 @default.
• W2260488093 cites W2144868623 @default.
• W2260488093 cites W2145676965 @default.
• W2260488093 cites W2149098343 @default.
• W2260488093 cites W2161437128 @default.
• W2260488093 cites W2165809374 @default.
• W2260488093 cites W2323087053 @default.
• W2260488093 cites W2975364463 @default.
• W2260488093 cites W88740342 @default.
• W2260488093 doi "https://doi.org/10.1016/j.ejphar.2016.01.002" @default.
• W2260488093 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26801071" @default.
• W2260488093 hasPublicationYear "2016" @default.
• W2260488093 type Work @default.
• W2260488093 sameAs 2260488093 @default.
• W2260488093 citedByCount "147" @default.
• W2260488093 countsByYear W22604880932016 @default.
• W2260488093 countsByYear W22604880932017 @default.
• W2260488093 countsByYear W22604880932018 @default.
• W2260488093 countsByYear W22604880932019 @default.
• W2260488093 countsByYear W22604880932020 @default.
• W2260488093 countsByYear W22604880932021 @default.
• W2260488093 countsByYear W22604880932022 @default.
• W2260488093 countsByYear W22604880932023 @default.
• W2260488093 crossrefType "journal-article" @default.
• W2260488093 hasAuthorship W2260488093A5036923059 @default.
• W2260488093 hasAuthorship W2260488093A5054459491 @default.
• W2260488093 hasAuthorship W2260488093A5054977676 @default.
• W2260488093 hasAuthorship W2260488093A5055299862 @default.
• W2260488093 hasAuthorship W2260488093A5056588504 @default.
• W2260488093 hasAuthorship W2260488093A5065018071 @default.
• W2260488093 hasAuthorship W2260488093A5069730600 @default.
• W2260488093 hasAuthorship W2260488093A5071911403 @default.
• W2260488093 hasAuthorship W2260488093A5091796903 @default.
• W2260488093 hasConcept C126322002 @default.
• W2260488093 hasConcept C134018914 @default.
• W2260488093 hasConcept C185592680 @default.
• W2260488093 hasConcept C2776151105 @default.
• W2260488093 hasConcept C2776848411 @default.
• W2260488093 hasConcept C2777391703 @default.
• W2260488093 hasConcept C2777952589 @default.
• W2260488093 hasConcept C2778004101 @default.

• next